McRoberts BV

Mobilise-D put out an informative short movie on the massive success of the project and all the efforts from everyone involved to get this far.

We're thrilled to announce that we integrated the Mobilise-D algorithm for computing Digital Mobility Outcomes in our analytics pipeline for use in clinical trials and healthcare. 💬 Here's what Prof. Lynn Rochester, Professor of Human Movement Science at Newcastle University and co-lead of the Mobilise-D Consortium had to say: “Implementation of the Mobilise-D methods by McRoberts represents a major milestone in delivering robust, valid digital mobility outcomes and marks an important step towards adoption in clinical trials and care.” These are the kind of developments that are needed to drive this field forward. Regulatory acceptance is the next step! 👉 Read the full story in our press release:  https://lnkd.in/eaQKrqKW

A recent study conducted by a team at Vrije Universiteit Amsterdam (VU Amsterdam) highlights the distinction between daily-life mobility and in-lab mobility assessments. The findings reveal that gait quality in everyday life does not correlate with performance on the Short Physical Performance Battery (SPPB) in community-dwelling older adults at an increased risk of falling. https://lnkd.in/e9NZbMAG

Embarking on the Next Steps of Mobilise-D This summer we integrated the Mobilise-D algorithm for computing Digital Mobility Outcomes in our analytics pipeline. This enables us to offer the 25 Mobilise-D measures to our clients for use in clinical trials and healthcare Our five-year involvement in the project has equipped us with extensive experience and the necessary tools to support our clients in exploiting these new developments in digital health technology.

🚀 The Finish Line: Mobilise-D Concluded! Last Friday marked the final day of the IMI project Mobilise-D ; the world's largest project on Digital Mobility Outcomes. It was truly a pleasure and honour to be part of this amazing consortium.  Mobilise-D is by far the largest project we’ve ever been part of. Excellent leadership and highly skilled people made this project to a huge success. After 5 years this project comes to an end. 5 years in which incredible progress has been made in this space. We believe that digital biomarkers have the potential to revolutionize healthcare and clinical trials. Mobilise-D, with its set of validated Digital Mobility Outcomes, will contribute significantly to this revolution. 📊 A list of our contributions in the past 5 years: • We supported 22 study sites for 3 years with data collection of about 2.500 subjects in the Clinical Validation Study  • 20.000 datasets were collected and analysed using our MyMcRoberts web portal  • We provided MoveMonitor and MoveTest results for all collected data to the consortium  • McRoberts requested qualification advice on behalf of the consortium for Digital Mobility Outcomes at the European Medicines Agency, which resulted in two Letters of Support from the EMA.  • We implemented the Mobilise-D algorithm into our analytics pipeline to analyse new and old data the Mobilise-D way. We support both DynaPort and Axivity sensor data. The newly formed SUSTAIN consortium will continue for another two years to analyse the massive amounts of data collected in this project. Also, RCTs will be conducted to show how useful these novel endpoints are in clinical research. #DigitalBiomarkers #mobilised

We’re at the 7th Annual Digital Biomarkers in Clinical Trials Summit in sunny Basel! 🇨🇭 Especially looking forward to the Mobilise-D talk later today. The project ends this month after 5 years! The presentation will reflect on the lessons learned in this multi-stakeholder project. #DigitalBiomarkersSummit

Hop by our booth if you're at #ICAMPAM2024!

This week we're in Rennes, France for the #ICAMPAM2024 It's always a pleasure to be at this biennially event, which lies at the heart of our work. This year's edition is extra special, as we share our booth with Empatica to showcase our new partnership. All 71 McRoberts endpoints can now be offered through their FDA-cleared Empatica Health Monitoring Platform Martijn Niessen and Ali Tabasi are at our booth to tell you all about the partnership and the latest developments we're working on.

Another week, another shipment! 💥 #thatsalotofsensors